[go: up one dir, main page]

ATE238339T1 - Verbindungen zur regulierung der meiose - Google Patents

Verbindungen zur regulierung der meiose

Info

Publication number
ATE238339T1
ATE238339T1 AT97948753T AT97948753T ATE238339T1 AT E238339 T1 ATE238339 T1 AT E238339T1 AT 97948753 T AT97948753 T AT 97948753T AT 97948753 T AT97948753 T AT 97948753T AT E238339 T1 ATE238339 T1 AT E238339T1
Authority
AT
Austria
Prior art keywords
compounds
meiosis
useful
compounds regulating
regulating meiosis
Prior art date
Application number
AT97948753T
Other languages
English (en)
Inventor
Christian Grondahl
Frederik Christian Gronvald
Peter Faarup
Anthony Murray
Jan Lund Ottesen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE238339T1 publication Critical patent/ATE238339T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • General Induction Heating (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
AT97948753T 1996-12-20 1997-12-19 Verbindungen zur regulierung der meiose ATE238339T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK147896 1996-12-20
US4148897P 1997-02-11 1997-02-11
PCT/DK1997/000584 WO1998028323A1 (en) 1996-12-20 1997-12-19 Meiosis regulating compounds

Publications (1)

Publication Number Publication Date
ATE238339T1 true ATE238339T1 (de) 2003-05-15

Family

ID=26065809

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97948753T ATE238339T1 (de) 1996-12-20 1997-12-19 Verbindungen zur regulierung der meiose

Country Status (12)

Country Link
US (3) US6486145B2 (de)
EP (1) EP0946584B1 (de)
JP (1) JP2001506656A (de)
KR (1) KR20000069616A (de)
AT (1) ATE238339T1 (de)
AU (1) AU746878B2 (de)
CA (1) CA2275683A1 (de)
DE (1) DE69721304T2 (de)
HU (1) HUP9904616A3 (de)
IL (1) IL130249A0 (de)
NO (1) NO313144B1 (de)
WO (1) WO1998028323A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030004148A1 (en) * 1994-06-23 2003-01-02 Byskov Anne G. Regulation of meiosis
CA2331962A1 (en) * 1998-05-13 1999-11-18 Novo Nordisk A/S Meiosis regulating compounds
IL139241A0 (en) * 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
WO1999067273A1 (en) * 1998-06-19 1999-12-29 Novo Nordisk A/S Meiosis regulating compounds
US6528501B1 (en) 1998-12-11 2003-03-04 Akzo Nobel N.V. 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
PL350557A1 (en) * 1999-02-10 2002-12-16 Schering Ag Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
AU2794000A (en) 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility
ES2258445T3 (es) 1999-02-24 2006-09-01 Novo Nordisk A/S Metodo in vitro para la sincronizacion de la maduracion de ovocitos.
AU2914800A (en) * 1999-03-02 2000-09-21 Akzo Nobel N.V. (androst-5-en-17beta-yl)alkyl sulfoxides and sulfones and their use for control of fertility
DE60000978T2 (de) * 1999-03-09 2003-07-17 Akzo Nobel N.V., Arnheim/Arnhem 22r-hydroxycholesta-8,14-diene derivate zur hemmung der meiose
US6902528B1 (en) * 1999-04-14 2005-06-07 Stereotaxis, Inc. Method and apparatus for magnetically controlling endoscopes in body lumens and cavities
EP1216059B1 (de) 1999-09-16 2005-10-19 Novo Nordisk A/S Zusammensetzung zur in-vitro befruchtung
EP1127890A1 (de) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid Derivate mit einem an Ring A des Steroidgerüstes kondensierten Ring zur Regulierung der Meiose
MXPA02007818A (es) * 2000-02-25 2002-10-23 Schering Ag Tasa de implantacion mejorada utilizando ff-mas.
WO2001076360A2 (en) * 2000-04-06 2001-10-18 Novo Nordisk A/S Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro
DE60225117T2 (de) * 2001-02-06 2009-02-26 Novo Nordisk A/S Behältnis mit niedrigem sauerstoffgehalt, das ff-mas enthält
US6988613B2 (en) 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF
EP1245572A1 (de) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol-Verbindungen, ihre Verwendung zur Herstellung Meiose-regulierender Medikamenten und ein Vefahren zu ihrer Herstellung
US8969543B2 (en) * 2003-04-03 2015-03-03 Bioneer Corporation SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof
US20080312673A1 (en) * 2007-06-05 2008-12-18 Viswanathan Raju R Method and apparatus for CTO crossing
WO2011127465A2 (en) 2010-04-09 2011-10-13 The Research Foundation Of The State University Of New York Ship inhibitors and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1224738B (de) 1960-12-29 1966-09-15 Takeda Chemical Industries Ltd Verfahren zur Herstellung von Cholestan-3, 5, 6-triol-3-estern oder -3, 6-diestern soowie von deren Salzen
DE1183079B (de) 1961-11-27 1964-12-10 Vismara Francesco Spa Verfahren zur Herstellung von gesaettigten 4-Hydroxy-3-keto-5alpha-steroiden
CH470374A (de) 1965-09-24 1969-03-31 Hoffmann La Roche Verfahren zur Herstellung von Steroiden
DE1593492A1 (de) 1966-01-29 1970-07-16 Schering Ag 6-Ketosteroide aus 20-Formyl-6-keto-Steroide
IL38540A0 (en) 1971-01-18 1972-03-28 Dauten Sa Method for the extraction of insect moulting steroid hormones
ZA725157B (en) 1971-07-29 1973-04-25 Dauten Sa New steroid of insecticide action and process for its production
US4670190A (en) 1973-01-10 1987-06-02 Hesse Robert H 1-α-hydroxy vitamin D compounds and process for preparing same
FR2219943B1 (de) 1973-03-02 1976-04-30 Eisai Co Ltd
IL41923A (en) 1973-04-01 1978-08-31 Yeda Res & Dev Preparation of hydroxylated derivatives of cholestanol and some such compounds
US3931403A (en) 1973-05-25 1976-01-06 Intellectual Property Development Corporation Antimicrobial compositions
US3887545A (en) 1973-11-12 1975-06-03 Hoffmann La Roche Synthesis of 1{60 -hydroxylated cholesterol derivatives
JPS5119752A (en) 1974-08-07 1976-02-17 Masayuki Ishikawa 1 arufua* 2 arufuaa jihidorokishikorekarushifuerooruno seiho
IL45897A (en) 1974-10-22 1978-12-17 Yeda Res & Dev Process for the preparation of 1 hydroxy-provitamin d3
JPS6039278B2 (ja) 1977-05-23 1985-09-05 中外製薬株式会社 ステロイド誘導体
EP0055999B1 (de) 1979-02-15 1984-10-03 Teijin Limited Vitamin D3
US4230626A (en) 1979-07-30 1980-10-28 G. D. Searle & Co. 25-Halocholest-5-ene-3β,22-diols and esters thereof
US4254045A (en) 1980-04-21 1981-03-03 Wisconsin Alumni Research Foundation 1α-Hydroxy-2β-fluorocholecalciferol
GB2089810B (en) 1980-09-22 1984-09-19 Wisconsin Alumni Res Found 23,25-dihydroxyvitamin d3 precursors
ATE15050T1 (de) 1981-04-29 1985-09-15 Hoffmann La Roche Verfahren zur herstellung von cholesterinderivaten und zwischenprodukte dafuer.
US4329295A (en) 1981-06-29 1982-05-11 G. D. Searle & Co. 24-Cyclopropylcholene-3β, 22-diols and esters thereof
US4348328A (en) 1981-11-09 1982-09-07 G.D. Searle & Co. 25-Substituted-5α-cholestane-3β,22S-diol
US4871727A (en) 1987-12-21 1989-10-03 Merck & Co, Inc. Anti-inflammatory and antidegenerative compounds isolated from L-681,512
JPH0749435B2 (ja) 1988-07-04 1995-05-31 帝人株式会社 １α，３β，２４−トリヒドロキシ−△▲上５▼−ステロイド類の製造方法
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
RU2188006C2 (ru) * 1995-03-06 2002-08-27 Ново Нордиск А/С Стимуляция мейоза

Also Published As

Publication number Publication date
JP2001506656A (ja) 2001-05-22
NO993009D0 (no) 1999-06-18
DE69721304D1 (de) 2003-05-28
US20010005757A1 (en) 2001-06-28
HUP9904616A3 (en) 2001-02-28
AU7878998A (en) 1998-07-17
CA2275683A1 (en) 1998-07-02
US20030032824A1 (en) 2003-02-13
DE69721304T2 (de) 2004-03-04
NO993009L (no) 1999-08-19
KR20000069616A (ko) 2000-11-25
US20050004382A1 (en) 2005-01-06
NO313144B1 (no) 2002-08-19
IL130249A0 (en) 2000-06-01
US6759400B2 (en) 2004-07-06
US6486145B2 (en) 2002-11-26
AU746878B2 (en) 2002-05-02
EP0946584A1 (de) 1999-10-06
EP0946584B1 (de) 2003-04-23
WO1998028323A1 (en) 1998-07-02
HUP9904616A2 (hu) 2000-06-28

Similar Documents

Publication Publication Date Title
ATE238339T1 (de) Verbindungen zur regulierung der meiose
AR003441A1 (es) Compuestos para regular la meiosis y el uso de los mismos para preparar medicamentos.
IL138402A0 (en) Heterocyclically substituted amides used as calpain inhibitors
MX9700174A (es) Derivados de esterol usados para la regulacion de la meiosis.
NZ335383A (en) Epothilone C,D,E and F for plant protection and cytostatic effects shown in kidney cells
DK155143C (da) Antioestrogent laegemiddel til behandling af benigne og canceroese tilstande i brystet
ES2175087T3 (es) Compuestos triciclicos utiles en el tratamiento de trastornos de proliferacion celular.
CO4290424A1 (es) Pirazolopiridinas, pirrolopiridinas, composiciones farmaceu- ticas que las contienen y procedimientos para su administra- cion como antagonista del factor de liberacion de cortico- tropina
ATE464287T1 (de) Cyclohexyl-sulphone als gamma-sekretase- inhibitoren
PT839154E (pt) Peptidos e composicoes biologicamente activos sua utilizacao
ES2153851T3 (es) Tratamiento de la atrofia de la piel y de la vagina.
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
DK0782567T3 (da) Isothiourinstofderivater og fremgangsmåder til deres fremstilling
ATE256144T1 (de) Verwendung von verbindungen mit der fähigkeit die meiose zu regulieren
TR199901275T2 (xx) Farnezil protein transferaz inhibisyonu i�in yararl� bile�ikler.
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
ATE209914T1 (de) Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
ATE177424T1 (de) N-substituierte naphthalimide, ihre herstellung und verwendung
DK0809627T3 (da) Hidtil ukendte borneolderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
NZ336042A (en) Farnesyl transferase inhibitors
DE59202744D1 (de) 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung.
HUP0102704A2 (hu) Meiózist befolyásoló szteroidok és alkalmazásuk
DE69532959D1 (de) D-ring modifizierte gibberellinverbindungen und ihre herstellung und verwendung
NO20016326D0 (no) Anvendelse av proteinet UK 114 for å hindre avstötning av organtransplantatet
TR199700975A2 (xx) Salg�n hastal�k ila�lar� (pepticides).

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties